Luma closes $410m debut life-sciences fund after scoring $1.55bn first exit
Thursday, September 10, 2026 · first reported by AltAssets
Luma Group closes debut life-sciences venture fund at $410m after securing first portfolio exit: Eli Lilly acquisition of portfolio company at $1.55bn.
- Firm
- Luma Group
- Also named
- Eli Lilly
- Fund
- Luma Life-Sciences Fund I
- Size
- $410M
- Stage
- Final close
- Asset class
- Venture
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- Forbion tops predecessor haul with €2.3bn dual fundraiseAlternatives Watch
- Niobrara Capital closes inaugural fund with more than $1.5bn in commitmentsPrivate Equity Wire +4
- Dig’s new fund bets on infrastructure built around foundation modelsVenture Capital Journal
- Linse Capital moves into early-stage deep tech with $150m Ignition strategyAltAssets
- NVM Ventures launches with €23.6M first close for dual-use startupsDealroom +3
- Venture Capital: Cypress Asia launches RM50 mil debut venture fund with New Hoong Fatt as anchor investortheedgemalaysia.com +2